Research Background

Dr. Jon Vanderhoof joined the faculty at the University of Nebraska College of Medicine in Omaha, Nebraska in 1976 and served as their first Chief of Pediatric Gastroenterology. During his time there, he was instrumental in initiating and developing the intestinal failure program and intestinal transplantation program at the institution. Dr. Vanderhoof was also Executive Director of the Center for Human Nutrition in Omaha and, for a five-year period, chaired the Department of Pediatrics at Creighton University, also in Omaha. In 2002, he became VP for Global Medical Affairs at Mead Johnson Nutrition, a position he held for 9 ½ years. Dr. Vanderhoof has since resumed his academic career at Boston Children’s Hospital.

Publications

  1. Infant formula with added Lacticaseibacillus rhamnosus GG supported adequate growth and was well tolerated in healthy term infants: a randomized controlled trial. Front Pediatr. 2024; 12:1456607. View Abstract
  2. Extensively Hydrolyzed Formula and Infant Colic Symptoms: Secondary Analysis of a Prospective Cohort Study. Clin Pediatr (Phila). 2024 Nov; 63(11):1579-1584. View Abstract
  3. Clinician Experience with Using Hypoallergenic Formulas to Treat Infants with Suspected Cow's Milk Protein Allergy: A Secondary Analysis of a Prospective Survey Cohort. Pediatr Gastroenterol Hepatol Nutr. 2023 Sep; 26(5):277-283. View Abstract
  4. Short-term symptom improvement in infants with suspected cow's milk protein allergy using amino acid formula: a prospective cohort analysis. Front Nutr. 2023; 10:1208334. View Abstract
  5. Pediatric Colonic Xanthomas, a Previously Unreported Colonoscopic Finding. JPGN Rep. 2023 Aug; 4(3):e329. View Abstract
  6. Extensively Hydrolyzed Formula Improves Allergic Symptoms in the Short Term in Infants with Suspected Cow's Milk Protein Allergy. Nutrients. 2023 Mar 30; 15(7). View Abstract
  7. The role of probiotics and postbiotics in modulating the gut microbiome-immune system axis in the pediatric age. Minerva Pediatr (Torino). 2021 Apr; 73(2):115-127. View Abstract
  8. Stool microbiome, pH and short/branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age. BMC Microbiol. 2020 11 09; 20(1):337. View Abstract
  9. Bifidobacterium longum Subspecies infantis (B. infantis) in Pediatric Nutrition: Current State of Knowledge. Nutrients. 2020 May 28; 12(6). View Abstract
  10. Stool pH and Short/Branched Chain Fatty Acids in Infants Receiving Extensively Hydrolyzed Formula, Amino Acid Formula, or Human Milk Through Two Months of Age (P11-076-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1). View Abstract
  11. Stool Microbiota in Infants Receiving Extensively Hydrolyzed Formula, Amino Acid Formula, or Human Milk Through Two Months of Age (FS04-07-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1). View Abstract
  12. Factors Associated with the Development of Immune Tolerance in Children with Cow's Milk Allergy. Int Arch Allergy Immunol. 2019; 179(4):290-296. View Abstract
  13. A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions. Front Immunol. 2018; 9:2059. View Abstract
  14. Chapter 4. The Relationship Between the European and North American Societies for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018 04; 66 Suppl 1:S44-S53. View Abstract
  15. An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning. J Allergy Clin Immunol. 2018 04; 141(4):1354-1364.e9. View Abstract
  16. Evaluation of an Amino Acid-Based Formula in Infants Not Responding to Extensively Hydrolyzed Protein Formula. J Pediatr Gastroenterol Nutr. 2016 11; 63(5):531-533. View Abstract
  17. Iron Requirements for Infants with Cow Milk Protein Allergy. J Pediatr. 2015 Oct; 167(4 Suppl):S36-9. View Abstract
  18. [In time: misuse and overuse of amino acid formulas in cow milk allergy]. Rev Paul Pediatr. 2015 12; 33(4):379-80. View Abstract
  19. Fermentation pattern of infant formulas containing different prebiotics. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):688-90. View Abstract
  20. Fecal calprotectin and pediatric juvenile polyps. J Pediatr Gastroenterol Nutr. 2015 Apr; 60(4):e30-1. View Abstract
  21. Allergic colitis in monozygotic preterm twins. Immunopharmacol Immunotoxicol. 2013 Feb; 35(1):198-201. View Abstract
  22. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. J Pediatr Gastroenterol Nutr. 2012 Mar; 54(3):343-52. View Abstract
  23. Stool pattern changes in toddlers consuming a follow-on formula supplemented with polydextrose and galactooligosaccharides. J Pediatr Gastroenterol Nutr. 2012 Feb; 54(2):288-90. View Abstract
  24. Probiotics in the management of children with allergy and other disorders of intestinal inflammation. Benef Microbes. 2010 Nov; 1(4):351-6. View Abstract
  25. Diagnosis of cow milk allergy in the gut, never an easy task. J Pediatr (Rio J). 2010 Jul-Aug; 86(4):259-60. View Abstract
  26. Collagenous colitis in a 4-year-old child: response to budesonide. J Pediatr Gastroenterol Nutr. 2010 Jun; 50(6):688-90. View Abstract
  27. Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants. Nutr J. 2009 Jun 19; 8:27. View Abstract
  28. National Institutes of Health Gastrointestinal Microbiota and Advances in Prebiotic and Probiotic Research conference summary. Gastroenterology. 2009 May; 136(5):1473-5. View Abstract
  29. Probiotics in allergy management. J Pediatr Gastroenterol Nutr. 2008 Nov; 47 Suppl 2:S38-40. View Abstract
  30. Hypoallergenicity and effects on growth and tolerance of a new amino acid-based formula with DHA and ARA. J Pediatr Gastroenterol Nutr. 2008 Nov; 47 Suppl 2:S60-1. View Abstract
  31. Probiotics in the United States. Clin Infect Dis. 2008 Feb 01; 46 Suppl 2:S67-72; discussion S144-51. View Abstract
  32. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr. 2007 Aug; 45(2):204-12. View Abstract
  33. Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. J Pediatr Gastroenterol Nutr. 2007 Mar; 44(3):359-64. View Abstract
  34. A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux. Dig Dis Sci. 2007 Feb; 52(2):457-62. View Abstract
  35. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):11-20. View Abstract
  36. Pediatric applications of probiotics. Gastroenterol Clin North Am. 2005 Sep; 34(3):451-63, viii-ix. View Abstract
  37. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005 Sep; 11(9):833-9. View Abstract
  38. Effect of a barley breakfast cereal on blood glucose and insulin response in normal and diabetic patients. Plant Foods Hum Nutr. 2005 Jun; 60(2):63-7. View Abstract
  39. Current and potential uses of probiotics. Ann Allergy Asthma Immunol. 2004 Nov; 93(5 Suppl 3):S33-7. View Abstract
  40. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004 Oct; 39(4):436-7; author reply 437. View Abstract
  41. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol. 2004 Sep; 99(9):1823-32. View Abstract
  42. Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol. 2004 Jul; 99(7):1386-95. View Abstract
  43. New and emerging therapies for short bowel syndrome in children. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 3:S769-71. View Abstract
  44. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004 Apr; 99(4):681-6. View Abstract
  45. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol. 2004 Mar 15; 4:5. View Abstract
  46. Functional liver recovery parallels autologous gut salvage in short bowel syndrome. J Pediatr Surg. 2004 Mar; 39(3):340-4; discussion 340-4. View Abstract
  47. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr. 2004 Mar; 38(3):293-7. View Abstract
  48. Hydrolyzed versus nonhydrolyzed protein diet in short bowel syndrome in children. J Pediatr Gastroenterol Nutr. 2004 Jan; 38(1):107. View Abstract
  49. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Pract Res Clin Gastroenterol. 2003 Dec; 17(6):997-1015. View Abstract
  50. Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux. Clin Pediatr (Phila). 2003 Jul-Aug; 42(6):483-95. View Abstract
  51. Overview of considerations for the pediatric patient receiving home parenteral and enteral nutrition. Nutr Clin Pract. 2003 Jun; 18(3):221-6. View Abstract
  52. Role of probiotics in the management of patients with food allergy. Ann Allergy Asthma Immunol. 2003 Jun; 90(6 Suppl 3):99-103. View Abstract
  53. Clinical quiz: windsock duodenal web. J Pediatr Gastroenterol Nutr. 2003 Apr; 36(4):491, 501. View Abstract
  54. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease. J Pediatr Gastroenterol Nutr. 2003 Feb; 36(2):293-4. View Abstract
  55. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr. 2003 Jan; 36(1):112-5. View Abstract
  56. New and emerging therapies for short bowel syndrome in children. Paediatr Drugs. 2003; 5(8):525-31. View Abstract
  57. Analysis of the effect of intestinal resection on rat ileal bile Acid transporter expression and on bile Acid and cholesterol homeostasis. Pediatr Res. 2002 Aug; 52(2):286-91. View Abstract
  58. Probiotics in pediatrics. Pediatrics. 2002 May; 109(5):956-8. View Abstract
  59. Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. Transplant Proc. 2002 May; 34(3):958-60. View Abstract
  60. Autoimmune enteropathy in a child: response to infliximab therapy. J Pediatr Gastroenterol Nutr. 2002 Mar; 34(3):312-6. View Abstract
  61. The Shwachman Award of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, 2001: acceptance. J Pediatr Gastroenterol Nutr. 2002 Feb; 34(2):109-10. View Abstract
  62. Functional foods and probiotics: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 2:S106-9. View Abstract
  63. Research agenda for pediatric gastroenterology, hepatology and nutrition: transplantation. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S275-80. View Abstract
  64. Allergic disorders of the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2001 Nov; 4(6):553-6. View Abstract
  65. Randomized clinical trial of soy formula with and without added fiber in antibiotic-induced diarrhea. J Pediatr. 2001 Oct; 139(4):578-82. View Abstract
  66. The role of eicosanoids in the process of adaptation following massive bowel resection in the rat. JPEN J Parenter Enteral Nutr. 2001 Sep-Oct; 25(5):275-81. View Abstract
  67. Allergic constipation: association with infantile milk allergy. Clin Pediatr (Phila). 2001 Jul; 40(7):399-402. View Abstract
  68. Probiotics: future directions. Am J Clin Nutr. 2001 Jun; 73(6):1152S-1155S. View Abstract
  69. Enteral nutrition in short bowel syndrome. Semin Pediatr Surg. 2001 May; 10(2):65-71. View Abstract
  70. Saccharomyces boulardii does not stimulate mucosal hyperplasia after intestinal resection in the rat. J Pediatr Gastroenterol Nutr. 2001 Apr; 32(4):454-7. View Abstract
  71. The role of probiotics in the treatment of intestinal infections and inflammation. Curr Opin Gastroenterol. 2001 Jan; 17(1):58-62. View Abstract
  72. Long-term outcome of intestinal lengthening. Transplant Proc. 2000 Sep; 32(6):1242-3. View Abstract
  73. A multicenter long-term safety and efficacy trial of preterm formula supplemented with long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr. 2000 Aug; 31(2):121-7. View Abstract
  74. What's new in the management of short gut syndrome in children. J Am Coll Surg. 2000 Jun; 190(6):725-36. View Abstract
  75. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol. 2000 Jun; 95(6):1506-15. View Abstract
  76. Randomized multicenter trial documenting the efficacy and safety of a lactose-free and a lactose-containing formula for term infants. J Am Diet Assoc. 2000 Feb; 100(2):212-7. View Abstract
  77. Nutrition in pediatric inflammatory bowel disease. Nutrition. 2000 Jan; 16(1):78-80. View Abstract
  78. Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr. 2000; 30 Suppl 2:S34-8. View Abstract
  79. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov; 135(5):564-8. View Abstract
  80. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age. J Pediatr Gastroenterol Nutr. 1999 Sep; 29(3):318-26. View Abstract
  81. Enteral and parenteral nutrition in patients with short-bowel syndrome. Eur J Pediatr Surg. 1999 Aug; 9(4):214-9. View Abstract
  82. Dietary lipids influence intestinal adaptation after massive bowel resection. J Pediatr Gastroenterol Nutr. 1999 Jan; 28(1):41-5. View Abstract
  83. Chronic diarrhea. Pediatr Rev. 1998 Dec; 19(12):418-22. View Abstract
  84. Molecular analysis of the adaptive response of intestinal bile acid transport after ileal resection in the rat. Gastroenterology. 1998 Nov; 115(5):1172-8. View Abstract
  85. Abnormal expression of brush-border membrane transporters in the duodenal mucosa of two patients with microvillus inclusion disease. J Pediatr Gastroenterol Nutr. 1998 Nov; 27(5):536-42. View Abstract
  86. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998 Sep; 27(3):323-32. View Abstract
  87. Pretransplant management and small bowel-liver transplantation in an infant with microvillus inclusion disease. J Pediatr Gastroenterol Nutr. 1998 Sep; 27(3):333-7. View Abstract
  88. Synchronous intestinal transplantation inhibits post resection adaptation. Transplant Proc. 1998 Sep; 30(6):2634-5. View Abstract
  89. Food hypersensitivity in children. Curr Opin Clin Nutr Metab Care. 1998 Sep; 1(5):419-22. View Abstract
  90. Transplanted small bowel and expression of the insulin-like growth factor binding proteins. Pediatr Transplant. 1998 Aug; 2(3):206-10. View Abstract
  91. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1998 Aug; 27(2):155-60. View Abstract
  92. Nutritional management of regurgitation in infants. J Am Coll Nutr. 1998 Aug; 17(4):308-16. View Abstract
  93. Immunonutrition: the role of carbohydrates. Nutrition. 1998 Jul-Aug; 14(7-8):595-8. View Abstract
  94. Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs. 1998 Jul-Aug; 21(4):156-61. View Abstract
  95. Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantation. Pediatr Transplant. 1998 May; 2(2):134-8. View Abstract
  96. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Pediatr. 1998 May; 132(5):830-5. View Abstract
  97. Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat. J Pediatr Gastroenterol Nutr. 1998 Mar; 26(3):241-4. View Abstract
  98. Production of insulin-like growth factor I (IGF-I) and IGF-binding proteins by rat intestinal stromal cells in vitro. Cell Mol Life Sci. 1998 Feb; 54(2):158-66. View Abstract
  99. Short-bowel syndrome in children and adults. Gastroenterology. 1997 Nov; 113(5):1767-78. View Abstract
  100. Intolerance to protein hydrolysate infant formulas: an underrecognized cause of gastrointestinal symptoms in infants. J Pediatr. 1997 Nov; 131(5):741-4. View Abstract
  101. Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. J Pediatr Gastroenterol Nutr. 1997 Sep; 25(3):327-31. View Abstract
  102. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr. 1997 Sep; 131(3):356-61. View Abstract
  103. Gastroenteric inflammation in children with ulcerative colitis. Am J Gastroenterol. 1997 Jul; 92(7):1209-12. View Abstract
  104. Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: a preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr. 1997 Jul; 25(1):93-7. View Abstract
  105. Use of soy fiber in acute diarrhea in infants and toddlers. Clin Pediatr (Phila). 1997 Mar; 36(3):135-9. View Abstract
  106. Soy-polysaccharide-supplemented soy formula enhances mucosal disaccharidase levels following massive small intestinal resection in rats. J Pediatr Gastroenterol Nutr. 1997 Feb; 24(2):140-5. View Abstract
  107. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr. 1997 Jan; 24(1):102-12. View Abstract
  108. Intestinal transplantation in children. Transplant Proc. 1996 Oct; 28(5):2752. View Abstract
  109. Results of IGF-1 studies show promise in the treatment of intestinal disorders. JPEN J Parenter Enteral Nutr. 1996 Sep-Oct; 20(5):315. View Abstract
  110. Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. Transplant Proc. 1996 Aug; 28(4):2370. View Abstract
  111. Living related donor liver transplantation at the University of Nebraska Medical Center (1996). Transplant Proc. 1996 Aug; 28(4):2382. View Abstract
  112. Combined liver/small bowel transplantation using a blood group compatible but nonidentical donor. Transplantation. 1996 Jun 27; 61(12):1782-3. View Abstract
  113. Short bowel syndrome. Clin Perinatol. 1996 Jun; 23(2):377-86. View Abstract
  114. Growth hormone did not enhance mucosal hyperplasia after small-bowel resection. Scand J Gastroenterol. 1996 Apr; 31(4):349-54. View Abstract
  115. Short bowel syndrome in children and small intestinal transplantation. Pediatr Clin North Am. 1996 Apr; 43(2):533-50. View Abstract
  116. Preliminary experience with intestinal transplantation in infants and children. Pediatrics. 1996 Apr; 97(4):443-8. View Abstract
  117. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation. J Cell Physiol. 1996 Feb; 166(2):396-406. View Abstract
  118. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J Pediatr. 1995 Dec; 127(6):881-7. View Abstract
  119. Effect of glutamine-supplemented elemental diet on mucosal adaptation following bowel resection in rats. J Pediatr Gastroenterol Nutr. 1995 Nov; 21(4):394-8. View Abstract
  120. Short bowel syndrome in children. Curr Opin Pediatr. 1995 Oct; 7(5):560-8. View Abstract
  121. Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg. 1995 Oct; 222(4):600-5; discussion 605-7. View Abstract
  122. On the importance of cholecystokinin in neonatal pancreatic growth and secretory development in guinea pigs. Pancreas. 1995 Jul; 11(1):38-47. View Abstract
  123. Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct. Biochem Biophys Res Commun. 1995 Jun 26; 211(3):707-13. View Abstract
  124. Immunosuppressive drugs and hypertrophic cardiomyopathy. Lancet. 1995 Jun 24; 345(8965):1644-5. View Abstract
  125. Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr. 1995; 21 Suppl 1:S60-2. View Abstract
  126. Effect of intestinal harvesting and perfusion on serum and tissue diamine oxidase levels. Transplant Proc. 1994 Jun; 26(3):1475-6. View Abstract
  127. Dexamethasone inhibits mucosal adaptation after small bowel resection. Am J Physiol. 1994 Mar; 266(3 Pt 1):G497-503. View Abstract
  128. Preoperative evaluation of donor liver volume in pediatric living related liver transplantation: how accurate is it? Transplant Proc. 1994 Feb; 26(1):135. View Abstract
  129. Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. Gastroenterology. 1994 Jan; 106(1):94-9. View Abstract
  130. Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr. 1993 Nov; 17(4):387-91. View Abstract
  131. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. J Pediatr Gastroenterol Nutr. 1993 Jul; 17(1):32-8. View Abstract
  132. Regulatory peptides and intestinal growth. Gastroenterology. 1993 Apr; 104(4):1205-8. View Abstract
  133. Postnatal development of circulating cholecystokinin and secretin, pancreatic growth, and exocrine function in guinea pigs. Int J Pancreatol. 1993 Feb; 13(1):1-13. View Abstract
  134. Magnesium acetate vs. magnesium gluconate supplementation in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1993 01; 16(1):104-5. View Abstract
  135. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology. 1992 Sep; 131(3):1359-68. View Abstract
  136. Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology. 1992 Jun; 102(6):1949-56. View Abstract
  137. Short bowel syndrome. J Pediatr Gastroenterol Nutr. 1992 May; 14(4):359-70. View Abstract
  138. Effects of oral supplementation of glutamine on small intestinal mucosal mass following resection. J Am Coll Nutr. 1992 Apr; 11(2):223-7. View Abstract
  139. A jejunoileal bypass rat model for rapid study of the effects of vitamin malabsorption. Int J Vitam Nutr Res. 1992; 62(1):43-6. View Abstract
  140. Influence of portagen and pregestimil on essential fatty acid status in infantile liver disease. Pediatrics. 1992 Jan; 89(1):151-4. View Abstract
  141. The intestinal absorption of 3-O-methyl-D-glucose in methotrexate-treated rats: an in vivo study of small bowel function. J Pediatr Gastroenterol Nutr. 1991 Nov; 13(4):360-6. View Abstract
  142. Effect of dietary menhaden oil on normal growth and development and on ameliorating mucosal injury in rats. Am J Clin Nutr. 1991 Aug; 54(2):346-50. View Abstract
  143. Experience with intestinal lengthening for the short-bowel syndrome. J Pediatr Surg. 1991 Jun; 26(6):721-4. View Abstract
  144. Long-term central venous access in pediatric liver transplantation recipients: role of percutaneous insertion of subclavian Broviac catheters. Transplant Proc. 1991 Jun; 23(3):1991. View Abstract
  145. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child. 1991 Mar; 145(3):302-5. View Abstract
  146. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991 Feb; 87(2):148-51. View Abstract
  147. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line. Endocrinology. 1990 Jun; 126(6):2998-3005. View Abstract
  148. Effects of dietary lipids on recovery from mucosal injury. Gastroenterology. 1990 May; 98(5 Pt 1):1226-31. View Abstract
  149. Suppression of diamine oxidase activity enhances postresection ileal proliferation in the rat. Gastroenterology. 1989 Jun; 96(6):1533-8. View Abstract
  150. Home TPN in sparsely populated areas. Nutr Clin Pract. 1989 Apr; 4(2):62-6. View Abstract
  151. Effects of dietary linoleic acid on mucosal adaptation after small bowel resection. Digestion. 1989; 44(2):57-65. View Abstract
  152. Liver transplantation therapy for children: Part 2. J Pediatr Gastroenterol Nutr. 1988 Nov-Dec; 7(6):797-815. View Abstract
  153. Nitrogen balance in adult hospitalized patients with the use of a pediatric amino acid model. Arch Surg. 1988 Oct; 123(10):1275-9. View Abstract
  154. Morphological and functional effects of 16,16-dimethyl-prostaglandin-E2 on mucosal adaptation after massive distal small bowel resection in the rat. Gut. 1988 Jun; 29(6):802-8. View Abstract
  155. Reduced mucosal prostaglandin synthesis after massive small bowel resection. Am J Physiol. 1988 Mar; 254(3 Pt 1):G373-7. View Abstract
  156. Liver transplantation therapy for children: Part 1. J Pediatr Gastroenterol Nutr. 1988 Mar-Apr; 7(2):157-66. View Abstract
  157. Essential fatty acid deficiency and postresection mucosal adaptation in the rat. Gastroenterology. 1988 Mar; 94(3):682-7. View Abstract
  158. Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Analog of human growth hormone. Dig Dis Sci. 1987 Nov; 32(11):1275-80. View Abstract
  159. Juvenile polysaccharidosis with cardioskeletal myopathy. Arch Pathol Lab Med. 1987 Oct; 111(10):977-82. View Abstract
  160. Failure of blind small bowel biopsy in the diagnosis of intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr. 1987 Sep-Oct; 6(5):803-5. View Abstract
  161. Short bowel syndrome in children and adults. J Enterostomal Ther. 1987 Jul-Aug; 14(4):168-73. View Abstract
  162. Hepatocarcinoma in a child with the Alagille syndrome. Am J Dis Child. 1987 Jun; 141(6):698-700. View Abstract
  163. Nutritional support for the infant with extrahepatic biliary atresia. J Pediatr. 1987 May; 110(5):679-86. View Abstract
  164. Augmentation of mucosal adaptation following massive small-bowel resection by 16,16-dimethyl-prostaglandin E2 in the rat. Digestion. 1987; 36(4):213-9. View Abstract
  165. Effect of zinc deficiency on mucosal hyperplasia following 70% bowel resection. Am J Clin Nutr. 1986 Nov; 44(5):670-7. View Abstract
  166. Growth of intestinal neomucosa on prosthetic materials. J Surg Res. 1986 Nov; 41(5):484-92. View Abstract
  167. Familial occurrence of protracted diarrhea of infancy. J Pediatr. 1986 Nov; 109(5):845-7. View Abstract
  168. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology. 1986 Nov-Dec; 6(6):1259-62. View Abstract
  169. Effect of pure zinc deficiency on glucose tolerance and insulin and glucagon levels. Am J Physiol. 1986 Sep; 251(3 Pt 1):E273-8. View Abstract
  170. Intestinal abnormalities with central nervous system malignancy. J Pediatr Gastroenterol Nutr. 1986 Jul-Aug; 5(4):665-70. View Abstract
  171. Effects of isolated zinc deficiency on the composition of skeletal muscle, liver and bone during growth in rats. J Nutr. 1986 Apr; 116(4):610-7. View Abstract
  172. Lack of correlation of small bowel biopsy and clinical course of patients with intractable diarrhea of infancy. Gastroenterology. 1986 Mar; 90(3):527-31. View Abstract
  173. Reduced effect of taxol on plasma protein secretion by developing rat liver. Toxicol Appl Pharmacol. 1986 Feb; 82(2):233-8. View Abstract
  174. The importance of luminal factors in neomucosal growth. J Surg Res. 1986 Feb; 40(2):126-32. View Abstract
  175. Effects of short-term isolated zinc deficiency on intestinal growth and activities of several brush border enzymes in weaning rats. Pediatr Res. 1985 Dec; 19(12):1333-6. View Abstract
  176. Effect of intestinal location on growth and function of neomucosa. J Surg Res. 1985 Jul; 39(1):68-75. View Abstract
  177. Intestinal tapering and lengthening for short bowel syndrome. J Pediatr Gastroenterol Nutr. 1985 Jun; 4(3):495-7. View Abstract
  178. Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr. 1984 Nov-Dec; 8(6):685-9. View Abstract
  179. Increasing inhibition of hepatic protein secretion by colchicine during development. Am J Physiol. 1984 Sep; 247(3 Pt 1):G311-8. View Abstract
  180. Comparison of techniques for growing small bowel neomucosa. J Surg Res. 1984 Apr; 36(4):401-6. View Abstract
  181. Effect of casein versus casein hydrolysate on mucosal adaptation following massive bowel resection in infant rats. J Pediatr Gastroenterol Nutr. 1984 Mar; 3(2):262-7. View Abstract
  182. Reduced effect of microtubule inhibitors on hepatic protein secretion in the fetal rat. Gastroenterology. 1984 Feb; 86(2):236-42. View Abstract
  183. Stability of vitamin and mineral concentrations of a low-birth-weight infant formula during continuous enteral feeding. J Pediatr Gastroenterol Nutr. 1983 Nov; 2(4):617-21. View Abstract
  184. Potential for mucosal adaptation following massive small bowel resection in 3-week-old versus 8-week-old rats. J Pediatr Gastroenterol Nutr. 1983 Nov; 2(4):672-6. View Abstract
  185. Effect of chronic ethanol ingestion on zinc absorption in rat small intestine. Dig Dis Sci. 1983 Jul; 28(7):604-8. View Abstract
  186. Hair and plasma zinc levels following exclusion of biliopancreatic secretions from functioning gastrointestinal tract in humans. Dig Dis Sci. 1983 Apr; 28(4):300-5. View Abstract
  187. Hepatic protein synthesis and secretion after jejunoileal bypass in the rat. Am J Clin Nutr. 1983 Jan; 37(1):82-6. View Abstract
  188. A new parenteral nutrition solution for the treatment of infants with gastrointestinal disorders. Acta Chir Scand Suppl. 1983; 517:69-78. View Abstract
  189. Continuous enteral feedings. An important adjunct to the management of complex congenital heart disease. Am J Dis Child. 1982 Sep; 136(9):825-7. View Abstract
  190. Zinc absorption following massive small-bowel resection in the rat. Dig Dis Sci. 1982 Sep; 27(9):789-93. View Abstract
  191. Current treatment of Reye's syndrome. Nebr Med J. 1982 Aug; 67(8):219-22. View Abstract
  192. Effect of antibiotics in the prevention of jejunoileal bypass-induced liver dysfunction. Digestion. 1982; 23(1):9-15. View Abstract
  193. Variation in liver histology in Alagille's syndrome. Am J Gastroenterol. 1981 Jun; 75(6):449-50. View Abstract
  194. A rapid procedure for small intestinal biopsy in infants and children. Gastroenterology. 1981 May; 80(5 pt 1):938-41. View Abstract
  195. Etiology of jejunoileal bypass-induced liver dysfunction in rats. Dig Dis Sci. 1981 Apr; 26(4):328-33. View Abstract
  196. Effect of improved absorption on development of jejunoileal bypass-induced liver dysfunction in rats. Dig Dis Sci. 1980 Aug; 25(8):581-6. View Abstract
  197. Role of defunctionalized bowel in jejunoileal bypass-induced liver disease in rats. Dig Dis Sci. 1979 Dec; 24(12):916-20. View Abstract
  198. Determination of the site of zinc absorption in rat small intestine. J Nutr. 1979 Jan; 109(1):142-7. View Abstract
  199. Manometric diagnosis of lower esophageal sphincter incompetence in infants: use of a small, single-lumen perfused catheter. Pediatrics. 1978 Nov; 62(5):805-8. View Abstract
  200. Impaired hepatic drug metabolism after jejunoileal bypass in rats. J Pharmacol Exp Ther. 1978 Jul; 206(1):167-71. View Abstract
  201. Esophageal ulcers in immunodeficiency with elevated levels of IgM and neutropenia. Am J Dis Child. 1977 May; 131(5):551-2. View Abstract
  202. Effects of nicotinic aicd on induction of hepatic drug metabolizing enzymes by chronic ethanol administration. Proc Soc Exp Biol Med. 1977 May; 155(1):67-70. View Abstract
  203. Proctosigmoidoscopy and rectal biopsy in infants and children. J Pediatr. 1976 Dec; 89(6):911-5. View Abstract
  204. Proctosigmoidoscopy and rectal biopsy in children. Pediatr Ann. 1976 Nov; 5(11):723-32. View Abstract
  205. Severe Coombs negative hemolytic anemia in hepatitis B. West J Med. 1976 Sep; 125(3):228-30. View Abstract
  206. Congenital chloridorrhea: unexplained growth retardation. Nebr Med J. 1976 Jul; 61(7):223-6. View Abstract
  207. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl. J Pediatr. 1976 May; 88(5):867-8. View Abstract
  208. Letter: Hiatal hernia and gastroesophageal reflux. J Pediatr. 1976 Apr; 88(4 Pt 1):693-5. View Abstract
  209. The role of exploratory laparotomy for chronic abdominal pain in children. Nebr Med J. 1974 Nov; 59(11):430-3. View Abstract

Contact Jon A. Vanderhoof

Print Profile